MAIA MAIA Biotechnology Inc

Price (delayed)

$1.5

Market cap

$91.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.67

Enterprise value

$56.79M

?
Relative Growth: Rel. Growth: 8
Relative Strength: Rel. Strength: 42
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1

We are a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. In ...

Highlights
MAIA Biotechnology's quick ratio has soared by 153% YoY
The EPS rose by 15% year-on-year and by 4.3% since the previous quarter
MAIA Biotechnology's net income has decreased by 23% YoY and by 8% from the previous quarter

Key stats

What are the main financial stats of MAIA

MAIA stock price

How has the MAIA Biotechnology stock price performed over time
Intraday
4.9%
1 week
16.28%
1 month
7.91%
1 year
-14.77%
YTD
-1.96%
QTD
7.14%

Financial performance

How have MAIA Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.79M
Net income
-$24.25M
Gross margin
N/A
Net margin
N/A
MAIA Biotechnology's operating income has decreased by 40% YoY and by 6% from the previous quarter
MAIA Biotechnology's net income has decreased by 23% YoY and by 8% from the previous quarter

Price vs fundamentals

How does MAIA's price correlate with its fundamentals

Growth

What is MAIA Biotechnology's growth rate over time

Valuation

What is MAIA Biotechnology stock price valuation
P/E
N/A
P/B
3.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 15% year-on-year and by 4.3% since the previous quarter
The stock's price to book (P/B) is 99% less than its last 4 quarters average of 315.1

Efficiency

How efficient is MAIA Biotechnology business performance
The company's return on equity has surged by 64% QoQ and by 52% YoY
The return on assets is up by 29% since the previous quarter and by 22% year-on-year

Dividends

What is MAIA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MAIA.

Financial health

How did MAIA Biotechnology financials performed over time
MAIA's total assets has surged by 198% year-on-year
MAIA Biotechnology's quick ratio has soared by 153% YoY
The debt is 100% less than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.